Sign in Sign up for free

Last updated: 18 June 2019 at 5:12am EST

Mark A Popovsky Net Worth




The estimated Net Worth of Mark A Popovsky is at least $354 Thousand dollars as of 1 May 2008. Mark Popovsky owns over 246 units of Haemonetics stock worth over $354,353 and over the last 20 years Mark sold HAE stock worth over $0.

Mark Popovsky HAE stock SEC Form 4 insiders trading

Mark has made over 12 trades of the Haemonetics stock since 2005, according to the Form 4 filled with the SEC. Most recently Mark bought 246 units of HAE stock worth $10,910 on 1 May 2008.

The largest trade Mark's ever made was exercising 10,000 units of Haemonetics stock on 2 January 2008 worth over $288,800. On average, Mark trades about 2,867 units every 73 days since 2005. As of 1 May 2008 Mark still owns at least 4,891 units of Haemonetics stock.

You can see the complete history of Mark Popovsky stock trades at the bottom of the page.



What's Mark Popovsky's mailing address?

Mark's mailing address filed with the SEC is 400 WOOD ROAD, , BRAINTREE, MA, 02184.

Insiders trading at Haemonetics

Over the last 21 years, insiders at Haemonetics have traded over $82,114,016 worth of Haemonetics stock and bought 334,931 units worth $14,646,550 . The most active insiders traders include Paul Black, Robert E Abernathy, and Brad Nutter. On average, Haemonetics executives and independent directors trade stock every 13 days with the average trade being worth of $539,753. The most recent stock trade was executed by Stewart W Strong on 26 July 2024, trading 4,312 units of HAE stock currently worth $393,039.



What does Haemonetics do?

haemonetics is the blood management company. our comprehensive portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood management continuum. collectively they help improve patient care, ensure patient safety, and reduce costs for blood and plasma collectors, hospitals, and patients around the world. our mission we believe that through proper blood management, our products and services can help our commercial plasma and blood center customers optimize their collection processes. we seek to help ensure a continual supply of high-quality plasma for biopharmaceuticals and blood components for therapeutic use at optimal costs, along with better blood management processes. working with our hospital customers, we seek to prevent a blood transfusion to the patient who doesn’t need one, or, if a transfusion is necessary, to ensure the transfusion of the right blood product, at the right time, in the right



What does Haemonetics's logo look like?

Haemonetics Corp. logo

Complete history of Mark Popovsky stock trades at Haemonetics

Date
#
Company
 Insider
Trans.
Transaction
 Shares Price per share Total value Shares after Source
1 May 2008 HAE Haemonetics Corp. Mark A Popovsky
Vice President and Corporate Medical Director
 Buy 246 $44.35 $10,910
1 May 2008
4,891 ↗
2 Jan 2008 HAE Haemonetics Corp. Mark A Popovsky
Vice President and Corporate Medical Director
 Option 10,000 $28.88 $288,800
2 Jan 2008
9,645 ↗
1 Nov 2007 HAE Haemonetics Corp. Mark A Popovsky
Vice President and Corporate Medical Director
 Buy 253 $40.66 $10,287
1 Nov 2007
4,645 ↗
2 Jul 2007 HAE Haemonetics Corp. Mark A Popovsky
Vice President and Corporate Medical Director
 Option 7,000 $22.72 $159,040
2 Jul 2007
10,552 ↗
1 May 2007 HAE Haemonetics Corp. Mark A Popovsky
Vice President and Corporate Medical Director
 Buy 282 $38.63 $10,894
1 May 2007
3,552 ↗
25 Apr 2007 HAE Haemonetics Corp. Mark A Popovsky
Vice President and Corporate Medical Director
 Option 7,000 $22.72 $159,040
25 Apr 2007
10,270 ↗
2 Feb 2007 HAE Haemonetics Corp. Mark A Popovsky
Vice President and Corporate Medical Director
 Option 10,000 $22.72 $227,200
2 Feb 2007
13,270 ↗
1 Nov 2006 HAE Haemonetics Corp. Mark A Popovsky
Vice President and Corporate Medical Director
 Buy 228 $38.76 $8,837
1 Nov 2006
3,270 ↗
1 May 2006 HAE Haemonetics Corp. Mark A Popovsky
Vice President and Corporate Medical Director
 Buy 258 $41.52 $10,712
1 May 2006
3,042 ↗
2 Feb 2006 HAE Haemonetics Corp. Mark A Popovsky
Vice President and Corporate Medical Director
 Option 7,000 $22.72 $159,040
2 Feb 2006
9,784 ↗
1 Nov 2005 HAE Haemonetics Corp. Mark A Popovsky
Vice President and Corporate Medical Director
 Buy 297 $35.88 $10,656
1 Nov 2005
2,784 ↗
2 May 2005 HAE Haemonetics Corp. Mark A Popovsky
Vice President and Corporate Medical Director
 Buy 441 $27.20 $11,995
2 May 2005
2,487 ↗


Haemonetics executives and stock owners

Haemonetics executives and other stock owners filed with the SEC include: